TP53 Y220C mutations in patients with myeloid malignancies Research Letter

  

Authors:	Gener-Ricos, G.; Bewersdorf, J. P.; Loghavi, S.; Bataller, A.; Goldberg, A. D.; Sasaki, K.; Famulare, C.; Takahashi, K.; Issa, G. C.; Borthakur, G.; Kadia, T. M.; Short, N. J.; Senapati, J.; Carter, B. Z.; Patel, K. P.; Kantarjian, H.; Andreeff, M.; Stein, E. M.; DiNardo, C. D.
Title:	TP53 Y220C mutations in patients with myeloid malignancies
Keywords:	adult; clinical article; aged; middle aged; myeloproliferative disorders; gene mutation; genetics; mutation; myeloproliferative disorder; clinical feature; cancer patient; letter; phenotype; gene; genetic predisposition to disease; prevalence; cohort analysis; protein p53; hematologic malignancy; myelodysplastic syndrome; diagnosis; tumor suppressor protein p53; tp53 protein, human; genetic predisposition; myelodysplastic syndromes; clinical outcome; acute myeloid leukemia; tp53 mutation; chip; humans; human; male; female; myeloid neoplasms; ccus; tp53 y220c gene
Journal Title:	Leukemia and Lymphoma
Volume:	65
Issue:	10
ISSN:	1042-8194
Publisher:	Taylor & Francis Group
Date Published:	2024-01-01
Start Page:	1511
End Page:	1515
Language:	English
DOI:	10.1080/10428194.2024.2363440
PUBMED:	38856690
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195581438&doi=10.1080%2f10428194.2024.2363440&partnerID=40&md5=9891f65d3e36b0e370712778c7279263
Notes:	Letter -- Erratum issued, see DOI: 10.1080/10428194.2024.2380965 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/220044